SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
+10.95%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$360M
AUM Growth
+$360M
(+91%)
Cap. Flow
+$112M
Cap. Flow
% of AUM
31.22%
Top 10 Holdings %
Top 10 Hldgs %
61.27%
Holding
86
New
21
Increased
12
Reduced
26
Closed
20
Top Buys
| 1 |
BioAtla
BCAB
|
$108M |
| 2 |
Galecto
GLTO
|
$18.9M |
| 3 |
NVTA
Invitae Corporation
NVTA
|
$10.2M |
| 4 |
C4 Therapeutics
CCCC
|
$8.9M |
| 5 |
Exelixis
EXEL
|
$7.84M |
Top Sells
| 1 |
OraSure Technologies
OSUR
|
$7.61M |
| 2 |
QuidelOrtho
QDEL
|
$6.75M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$6.49M |
| 4 |
Sarepta Therapeutics
SRPT
|
$6.48M |
| 5 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$6.35M |
Sector Composition
| 1 | Healthcare | 90.41% |
| 2 | Consumer Staples | 2.45% |
| 3 | Real Estate | 0.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Sarepta Therapeutics
SRPT
$1.78B
| – | – | -46,166 | Closed | -$6.48M |
|
77
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | 0 | – | – |
|
78
Zynex
ZYXI
$49.7M
| – | – | -118,047 | Closed | -$2.06M |
|
|
AXNX
79
DELISTED
Axonics, Inc. Common Stock
AXNX
| – | – | -54,089 | Closed | -$2.76M |
|
|
HARP
80
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| – | – | -42,472 | Closed | -$722K |
|
|
ARNA
81
DELISTED
Arena Pharmaceuticals Inc
ARNA
| – | – | -10,977 | Closed | -$821K |
|
|
CNST
82
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| – | – | -10,742 | Closed | -$218K |
|
|
IMMU
83
DELISTED
Immunomedics Inc
IMMU
| – | – | -76,268 | Closed | -$6.49M |
|